Literature DB >> 525851

Parenteral vaccination of young swine against Bordetella bronchiseptica.

D O Farrington, W P Switzer.   

Abstract

The efficacy of Bordetella bronchiseptica bacterins for the prevention of nasal turbinate atrophy caused by induced B bronchiseptica infection in young swine was evaluated. Vaccination of pigs at an early age (eg, at 1 and 4 weeks of age) with potent B bronchiseptica strain D-1 bacterins resulted in high concentrations of circulating antibody up to 12 weeks of age or longer and in a significant (P less than 0.01) reduction in the frequency of turbinate atrophy.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 525851

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN： 0002-9645            Impact factor:   1.156


  6 in total

1.  Isolation and characterization of mutant strains of Bordetella bronchiseptica lacking dermonecrotic toxin-producing ability.

Authors:  H Nagano; T Nakai; Y Horiguchi; K Kume
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

Review 2.  Biology of Bordetella bronchiseptica.

Authors:  R A Goodnow
Journal:  Microbiol Rev       Date:  1980-12

3.  Interspecies variations in Bordetella catecholamine receptor gene regulation and function.

Authors:  Timothy J Brickman; Ryan J Suhadolc; Sandra K Armstrong
Journal:  Infect Immun       Date:  2015-09-14       Impact factor: 3.441

Review 4.  Human infections associated with Bordetella bronchiseptica.

Authors:  B F Woolfrey; J A Moody
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

5.  Alcaligin siderophore production by Bordetella bronchiseptica strain RB50 is not repressed by the BvgAS virulence control system.

Authors:  Timothy J Brickman; Sandra K Armstrong
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

6.  Isolation and characterization of Bordetella bronchiseptica mutants deficient in siderophore activity.

Authors:  S K Armstrong; M O Clements
Journal:  J Bacteriol       Date:  1993-02       Impact factor: 3.490
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.